Ticker Wall Street doesn’t want you to have
Former hedge fund manager Teeka Tiwari just released the name of his top pick for you to play this $867 trillion wrecking ball…

Details on 5 more tickers that could deliver 10X gains in the coming months as this massive financial trend picks up steam.
Click here to get the name of his top ticker
Stephen Hoge, insider at Moderna
Stephen Hoge Insider Alerts

Get notified the next time Stephen Hoge buys or sells Moderna stock. Enter your email address below to get our daily insider buying and selling report.

Stephen Hoge Insider Information

President of Moderna
Stephen Hoge serves as the President of Moderna and leads all Research & Development for the company. Since Moderna’s early days, Dr. Hoge has led our scientific efforts, including the creation of our platform and therapeutic areas. More recently, he has assumed responsibility for the company’s Clinical Development Office. He joined Moderna in late 2012 from McKinsey & Company, where he was a partner in the healthcare practice. Prior to McKinsey, Dr. Hoge was a resident physician in New York City.

He holds an M.D. with thesis from the University of California, San Francisco, and a B.S. in neuroscience from Amherst College.

Currently, Dr. Hoge also serves on the Board of Directors of Axcella Health, Inc., a publicly traded, clinical-stage biotechnology company.

What is Stephen Hoge's net worth?

The estimated net worth of Stephen Hoge is at least $258.45 million as of September 13th, 2021. Dr. Hoge owns 1,614,597 shares of Moderna stock worth more than $258,448,542 as of January 23rd. This net worth approximation does not reflect any other assets that Dr. Hoge may own. Learn More.

What is Stephen Hoge's salary?

As the President of Moderna, Inc., Dr. Hoge earned a total compensation package of $4,247,823.00 in 2020. Dr. Hoge earned a salary of $548,712.00, a bonus of $662,400.00, stock awards of $750,000.00, options awards of $2,250,000.00, and other compensation of $36,711.00.

How do I contact Stephen Hoge?

The corporate mailing address for Dr. Hoge and other Moderna executives is 200 TECHNOLOGY SQUARE, CAMBRIDGE MA, 02139. Moderna can also be reached via phone at (617) 714-6500 and via email at [email protected]

Has Stephen Hoge been buying or selling shares of Moderna?

During the past quarter, Stephen Hoge has sold $3,293,400.00 of Moderna stock. Most recently, Stephen Hoge sold 15,000 shares of the business's stock in a transaction on Thursday, January 13th. The shares were sold at an average price of $219.56, for a transaction totalling $3,293,400.00.

Who are Moderna's active insiders?

Moderna's insider roster includes Noubar Afeyan (Director), Juan Andres (Insider), Stephane Bancel (CEO), W. Cornwell (Director), Lori Henderson (General Counsel), Lori Henderson (General Counsel), Stephen Hoge (President), and Tal Zaks (Insider).

Are insiders buying or selling shares of Moderna?

During the last year, Moderna insiders bought shares 3 times. They purchased a total of 423,616 shares worth more than $15,619,184.48. During the last year, insiders at the sold shares 204 times. They sold a total of 6,927,278 shares worth more than $1,174,938,190.23. The most recent insider tranaction occured on January, 19th when CEO Stephane Bancel sold 9,000 shares worth more than $1,696,950.00. Insiders at Moderna own 19.4 % of the company.

Information on this page was last updated on 1/19/2022.

Stephen Hoge Insider Trading History at Moderna

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/13/2022Sell15,000$219.56$3,293,400.00View SEC Filing Icon  
12/27/2021Sell5,000$243.10$1,215,500.00View SEC Filing Icon  
12/23/2021Sell15,000$247.30$3,709,500.00View SEC Filing Icon  
12/13/2021Sell20,000$257.01$5,140,200.00View SEC Filing Icon  
12/2/2021Sell10,000$301.29$3,012,900.00View SEC Filing Icon  
11/15/2021Sell15,000$231.01$3,465,150.00View SEC Filing Icon  
11/12/2021Sell5,000$225.86$1,129,300.00View SEC Filing Icon  
11/3/2021Sell10,000$350.00$3,500,000.00View SEC Filing Icon  
10/25/2021Sell20,000$331.80$6,636,000.00View SEC Filing Icon  
10/13/2021Sell15,000$314.90$4,723,500.00View SEC Filing Icon  
10/4/2021Sell20,000$307.54$6,150,800.00View SEC Filing Icon  
9/24/2021Sell5,000$448.04$2,240,200.00View SEC Filing Icon  
9/13/2021Sell20,000$447.41$8,948,200.001,614,597View SEC Filing Icon  
9/2/2021Sell10,000$393.13$3,931,300.001,619,597View SEC Filing Icon  
8/13/2021Sell15,000$405.00$6,075,000.001,614,597View SEC Filing Icon  
7/26/2021Sell5,000$351.99$1,759,950.005,000View SEC Filing Icon  
7/23/2021Sell15,000$335.13$5,026,950.001,614,597View SEC Filing Icon  
7/13/2021Sell15,000$238.87$3,583,050.001,614,597View SEC Filing Icon  
7/6/2021Sell10,000$229.62$2,296,200.001,619,597View SEC Filing Icon  
6/23/2021Sell15,000$216.20$3,243,000.001,614,597View SEC Filing Icon  
6/14/2021Sell20,000$213.32$4,266,400.001,614,597View SEC Filing Icon  
5/3/2021Sell20,000$183.66$3,673,200.00
4/23/2021Sell15,000$172.19$2,582,850.001,614,597View SEC Filing Icon  
4/13/2021Sell15,000$146.62$2,199,300.001,614,597View SEC Filing Icon  
4/5/2021Sell20,000$132.63$2,652,600.001,619,597View SEC Filing Icon  
3/24/2021Sell5,000$137.07$685,350.001,614,597View SEC Filing Icon  
3/15/2021Sell15,000$137.00$2,055,000.001,614,597View SEC Filing Icon  
3/12/2021Sell5,000$134.04$670,200.001,614,597View SEC Filing Icon  
2/23/2021Sell15,000$147.08$2,206,200.001,629,597View SEC Filing Icon  
2/12/2021Sell5,000$185.00$925,000.001,624,597View SEC Filing Icon  
2/3/2021Sell20,000$157.46$3,149,200.00
1/25/2021Sell20,000$140.97$2,819,400.001,649,597View SEC Filing Icon  
1/13/2021Sell15,000$123.70$1,855,500.001,644,597View SEC Filing Icon  
12/23/2020Sell10,000$124.14$1,241,400.001,734,597View SEC Filing Icon  
12/14/2020Sell20,000$163.63$3,272,600.001,744,597View SEC Filing Icon  
12/2/2020Sell10,000$138.57$1,385,700.001,744,597View SEC Filing Icon  
11/24/2020Sell5,000$97.93$489,650.001,754,597View SEC Filing Icon  
11/13/2020Sell20,000$86.82$1,736,400.00
10/26/2020Sell5,000$69.99$349,950.001,926,530View SEC Filing Icon  
10/23/2020Sell15,000$70.02$1,050,300.001,926,530View SEC Filing Icon  
10/12/2020Sell5,000$74.46$372,300.001,925,521View SEC Filing Icon  
10/5/2020Sell10,000$69.50$695,000.001,936,530View SEC Filing Icon  
10/2/2020Sell10,000$67.86$678,600.001,936,530View SEC Filing Icon  
9/24/2020Sell20,000$66.72$1,334,400.001,946,530View SEC Filing Icon  
9/14/2020Sell20,000$61.42$1,228,400.001,956,530View SEC Filing Icon  
9/2/2020Sell10,000$62.89$628,900.001,956,530View SEC Filing Icon  
8/24/2020Sell20,000$64.99$1,299,800.001,966,530View SEC Filing Icon  
8/13/2020Sell20,000$69.03$1,380,600.00
8/3/2020Sell20,000$74.89$1,497,800.001,976,530View SEC Filing Icon  
7/24/2020Sell20,000$78.86$1,577,200.001,986,530View SEC Filing Icon  
7/13/2020Sell10,000$69.92$699,200.001,986,530View SEC Filing Icon  
7/6/2020Sell10,000$58.48$584,800.001,986,540View SEC Filing Icon  
7/2/2020Sell10,000$59.94$599,400.001,986,540View SEC Filing Icon  
6/23/2020Sell5,000$63.69$318,450.001,983,531View SEC Filing Icon  
6/15/2020Sell10,000$63.32$633,200.00
5/26/2020Sell10,000$61.85$618,500.002,005,495View SEC Filing Icon  
5/12/2020Sell5,000$64.50$322,500.002,015,657View SEC Filing Icon  
4/23/2020Sell5,000$49.02$245,100.002,025,140View SEC Filing Icon  
3/23/2020Sell5,000$27.93$139,650.002,045,267View SEC Filing Icon  
1/23/2020Sell5,000$21.99$109,950.002,081,915View SEC Filing Icon  
1/13/2020Sell10,000$19.14$191,400.002,086,530View SEC Filing Icon  
See Full Table

Stephen Hoge Buying and Selling Activity at Moderna

This chart shows Stephen Hoge's buying and selling at Moderna by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Moderna Company Overview

Moderna logo
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Read More

Today's Range

Now: $160.07
Low: $157.29
High: $171.25

50 Day Range

MA: $254.17
Low: $160.07
High: $368.51

2 Week Range

Now: $160.07
Low: $117.34
High: $497.49

Volume

11,767,762 shs

Average Volume

9,828,053 shs

Market Capitalization

$64.90 billion

P/E Ratio

9.81

Dividend Yield

N/A

Beta

1.22
5 Free Wealth Stock Picks
5 free stock picks that could set you up for a fresh new start in 2022.
Learn More.